explore -WSS

explore

author：focus 2025-10-01 00:47:42 - browse：23579

The state’s celebrated cluster of biotechs has hatched breakthrough medicines for everything from COVID and cystic fibrosis to multiple rare diseases. It has pioneered cutting-edge research in exotic fields like messenger RNA, gene editing, and gene therapies.

But when it comes to what is arguably the hottest space in drug development today — controlling weight and diabetes for millions of people worldwide — the brainy innovators from Kendall Square have missed out on the booming market, at least so far.

Instead, the field, which has scientific roots in Massachusetts, is dominated by a pair of global pharma giants: Denmark’s Novo Nordisk, maker of the blockbuster drugs Wegovy and Ozempic, and Indianapolis-based Eli Lilly, which produces the fast-selling Mounjaro.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Companies helping big Covid

focus

WSS

NIH documents show early flaws of $1.6 billion long Covid program

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Inflation cooled significantly in June, bringing price hikes close to normal levels

Shifting the focus from loneliness to social health

Let's speed up science by embracing open access publishing

explore

explore

hotspot

Heart attack and stroke risk calculators need revising

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

Supreme Court strikes down use of affirmative action

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

Cancer drug shortages should be causing more outrage

One Duchenne patient's bittersweet hope for new treatment

DIEP, the 'gold standard' of breast reconstruction, is under threat

France's anti

Trump demands the U.S. pay no more for drugs than other countries … again

One Duchenne patient's bittersweet hope for new treatment

knowledge

Digital health funding stays low as a new reality sets in

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

ASCO: AstraZeneca says CAR

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

Superbugs, antibiotic resistance get scrutiny in congress

Change Healthcare can notify patients about the breach, HHS says

focus

Wikipedia

focus

knowledge